Global Biothrax (Anthrax Vaccine) Market Research Report 2026(Status and Outlook)
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Biothrax (Anthrax Vaccine) market size was estimated at USD 727.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biothrax (Anthrax Vaccine) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biothrax (Anthrax Vaccine) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biothrax (Anthrax Vaccine) market.
Global Biothrax (Anthrax Vaccine) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biog?nesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Sant? Animale
Intervac
JOVAC
Market Segmentation (by Type)
Live Vaccines
Cell Free PA Vaccines
Market Segmentation (by Application)
Human Use
Animal Use
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biothrax (Anthrax Vaccine) Market
Overview of the regional outlook of the Biothrax (Anthrax Vaccine) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biothrax (Anthrax Vaccine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biothrax (Anthrax Vaccine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Biothrax (Anthrax Vaccine) market size was estimated at USD 727.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biothrax (Anthrax Vaccine) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biothrax (Anthrax Vaccine) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biothrax (Anthrax Vaccine) market.
Global Biothrax (Anthrax Vaccine) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biog?nesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Sant? Animale
Intervac
JOVAC
Market Segmentation (by Type)
Live Vaccines
Cell Free PA Vaccines
Market Segmentation (by Application)
Human Use
Animal Use
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biothrax (Anthrax Vaccine) Market
Overview of the regional outlook of the Biothrax (Anthrax Vaccine) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biothrax (Anthrax Vaccine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biothrax (Anthrax Vaccine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biothrax (Anthrax Vaccine)
1.2 Key Market Segments
1.2.1 Biothrax (Anthrax Vaccine) Segment by Type
1.2.2 Biothrax (Anthrax Vaccine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTHRAX (ANTHRAX VACCINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTHRAX (ANTHRAX VACCINE) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biothrax (Anthrax Vaccine) Product Life Cycle
3.3 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2020-2025)
3.4 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2020-2025)
3.5 Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
3.8.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOTHRAX (ANTHRAX VACCINE) INDUSTRY CHAIN ANALYSIS
4.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTHRAX (ANTHRAX VACCINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biothrax (Anthrax Vaccine) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biothrax (Anthrax Vaccine) Market
5.7 ESG Ratings of Leading Companies
6 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2020-2025)
6.3 Global Biothrax (Anthrax Vaccine) Market Size by Type (2020-2025)
6.4 Global Biothrax (Anthrax Vaccine) Price by Type (2020-2025)
7 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biothrax (Anthrax Vaccine) Market Sales by Application (2020-2025)
7.3 Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Application (2020-2025)
7.4 Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2020-2025)
8 BIOTHRAX (ANTHRAX VACCINE) MARKET SALES BY REGION
8.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region
8.2 Global Biothrax (Anthrax Vaccine) Market Size by Region
8.2.1 Global Biothrax (Anthrax Vaccine) Market Size by Region
8.2.2 Global Biothrax (Anthrax Vaccine) Market Size by Region
8.3 North America
8.3.1 North America Biothrax (Anthrax Vaccine) Sales by Country
8.3.2 North America Biothrax (Anthrax Vaccine) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
8.4.2 Europe Biothrax (Anthrax Vaccine) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
8.5.2 Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biothrax (Anthrax Vaccine) Sales by Country
8.6.2 South America Biothrax (Anthrax Vaccine) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region
8.7.2 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOTHRAX (ANTHRAX VACCINE) MARKET PRODUCTION BY REGION
9.1 Global Production of Biothrax (Anthrax Vaccine) by Region(2020-2025)
9.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2020-2025)
9.3 Global Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biothrax (Anthrax Vaccine) Production
9.4.1 North America Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.4.2 North America Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biothrax (Anthrax Vaccine) Production
9.5.1 Europe Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.5.2 Europe Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biothrax (Anthrax Vaccine) Production (2020-2025)
9.6.1 Japan Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.6.2 Japan Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biothrax (Anthrax Vaccine) Production (2020-2025)
9.7.1 China Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.7.2 China Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merial
10.1.1 Merial Basic Information
10.1.2 Merial Biothrax (Anthrax Vaccine) Product Overview
10.1.3 Merial Biothrax (Anthrax Vaccine) Product Market Performance
10.1.4 Merial Business Overview
10.1.5 Merial SWOT Analysis
10.1.6 Merial Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Biothrax (Anthrax Vaccine) Product Overview
10.2.3 Merck Biothrax (Anthrax Vaccine) Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Zoetis
10.3.1 Zoetis Basic Information
10.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Overview
10.3.3 Zoetis Biothrax (Anthrax Vaccine) Product Market Performance
10.3.4 Zoetis Business Overview
10.3.5 Zoetis SWOT Analysis
10.3.6 Zoetis Recent Developments
10.4 Bayer Sanidad Animal
10.4.1 Bayer Sanidad Animal Basic Information
10.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
10.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Market Performance
10.4.4 Bayer Sanidad Animal Business Overview
10.4.5 Bayer Sanidad Animal Recent Developments
10.5 Colorado Serum
10.5.1 Colorado Serum Basic Information
10.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
10.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Product Market Performance
10.5.4 Colorado Serum Business Overview
10.5.5 Colorado Serum Recent Developments
10.6 PharmAthene
10.6.1 PharmAthene Basic Information
10.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Overview
10.6.3 PharmAthene Biothrax (Anthrax Vaccine) Product Market Performance
10.6.4 PharmAthene Business Overview
10.6.5 PharmAthene Recent Developments
10.7 Tiankang
10.7.1 Tiankang Basic Information
10.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Overview
10.7.3 Tiankang Biothrax (Anthrax Vaccine) Product Market Performance
10.7.4 Tiankang Business Overview
10.7.5 Tiankang Recent Developments
10.8 Biog?nesis-Bago
10.8.1 Biog?nesis-Bago Basic Information
10.8.2 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Overview
10.8.3 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Market Performance
10.8.4 Biog?nesis-Bago Business Overview
10.8.5 Biog?nesis-Bago Recent Developments
10.9 CAVAC
10.9.1 CAVAC Basic Information
10.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Overview
10.9.3 CAVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.9.4 CAVAC Business Overview
10.9.5 CAVAC Recent Developments
10.10 Rosenbusch
10.10.1 Rosenbusch Basic Information
10.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
10.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Product Market Performance
10.10.4 Rosenbusch Business Overview
10.10.5 Rosenbusch Recent Developments
10.11 Agrovet
10.11.1 Agrovet Basic Information
10.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Overview
10.11.3 Agrovet Biothrax (Anthrax Vaccine) Product Market Performance
10.11.4 Agrovet Business Overview
10.11.5 Agrovet Recent Developments
10.12 Vecol
10.12.1 Vecol Basic Information
10.12.2 Vecol Biothrax (Anthrax Vaccine) Product Overview
10.12.3 Vecol Biothrax (Anthrax Vaccine) Product Market Performance
10.12.4 Vecol Business Overview
10.12.5 Vecol Recent Developments
10.13 CVCRI
10.13.1 CVCRI Basic Information
10.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Overview
10.13.3 CVCRI Biothrax (Anthrax Vaccine) Product Market Performance
10.13.4 CVCRI Business Overview
10.13.5 CVCRI Recent Developments
10.14 IVPM
10.14.1 IVPM Basic Information
10.14.2 IVPM Biothrax (Anthrax Vaccine) Product Overview
10.14.3 IVPM Biothrax (Anthrax Vaccine) Product Market Performance
10.14.4 IVPM Business Overview
10.14.5 IVPM Recent Developments
10.15 Prondil
10.15.1 Prondil Basic Information
10.15.2 Prondil Biothrax (Anthrax Vaccine) Product Overview
10.15.3 Prondil Biothrax (Anthrax Vaccine) Product Market Performance
10.15.4 Prondil Business Overview
10.15.5 Prondil Recent Developments
10.16 CDV
10.16.1 CDV Basic Information
10.16.2 CDV Biothrax (Anthrax Vaccine) Product Overview
10.16.3 CDV Biothrax (Anthrax Vaccine) Product Market Performance
10.16.4 CDV Business Overview
10.16.5 CDV Recent Developments
10.17 Indian Immunologicals
10.17.1 Indian Immunologicals Basic Information
10.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
10.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Market Performance
10.17.4 Indian Immunologicals Business Overview
10.17.5 Indian Immunologicals Recent Developments
10.18 Botswana Vaccine Institute
10.18.1 Botswana Vaccine Institute Basic Information
10.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
10.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Market Performance
10.18.4 Botswana Vaccine Institute Business Overview
10.18.5 Botswana Vaccine Institute Recent Developments
10.19 Ceva Sant? Animale
10.19.1 Ceva Sant? Animale Basic Information
10.19.2 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Overview
10.19.3 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Market Performance
10.19.4 Ceva Sant? Animale Business Overview
10.19.5 Ceva Sant? Animale Recent Developments
10.20 Intervac
10.20.1 Intervac Basic Information
10.20.2 Intervac Biothrax (Anthrax Vaccine) Product Overview
10.20.3 Intervac Biothrax (Anthrax Vaccine) Product Market Performance
10.20.4 Intervac Business Overview
10.20.5 Intervac Recent Developments
10.21 JOVAC
10.21.1 JOVAC Basic Information
10.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Overview
10.21.3 JOVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.21.4 JOVAC Business Overview
10.21.5 JOVAC Recent Developments
11 BIOTHRAX (ANTHRAX VACCINE) MARKET FORECAST BY REGION
11.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast
11.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.3 Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region
11.2.4 South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biothrax (Anthrax Vaccine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Biothrax (Anthrax Vaccine) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Type (2026-2035)
12.1.2 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Biothrax (Anthrax Vaccine) by Type (2026-2035)
12.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Application (2026-2035)
12.2.1 Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application
12.2.2 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biothrax (Anthrax Vaccine)
1.2 Key Market Segments
1.2.1 Biothrax (Anthrax Vaccine) Segment by Type
1.2.2 Biothrax (Anthrax Vaccine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTHRAX (ANTHRAX VACCINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTHRAX (ANTHRAX VACCINE) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biothrax (Anthrax Vaccine) Product Life Cycle
3.3 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2020-2025)
3.4 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2020-2025)
3.5 Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
3.8.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BIOTHRAX (ANTHRAX VACCINE) INDUSTRY CHAIN ANALYSIS
4.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTHRAX (ANTHRAX VACCINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biothrax (Anthrax Vaccine) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Biothrax (Anthrax Vaccine) Market
5.7 ESG Ratings of Leading Companies
6 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2020-2025)
6.3 Global Biothrax (Anthrax Vaccine) Market Size by Type (2020-2025)
6.4 Global Biothrax (Anthrax Vaccine) Price by Type (2020-2025)
7 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biothrax (Anthrax Vaccine) Market Sales by Application (2020-2025)
7.3 Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Application (2020-2025)
7.4 Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2020-2025)
8 BIOTHRAX (ANTHRAX VACCINE) MARKET SALES BY REGION
8.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region
8.2 Global Biothrax (Anthrax Vaccine) Market Size by Region
8.2.1 Global Biothrax (Anthrax Vaccine) Market Size by Region
8.2.2 Global Biothrax (Anthrax Vaccine) Market Size by Region
8.3 North America
8.3.1 North America Biothrax (Anthrax Vaccine) Sales by Country
8.3.2 North America Biothrax (Anthrax Vaccine) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
8.4.2 Europe Biothrax (Anthrax Vaccine) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
8.5.2 Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Biothrax (Anthrax Vaccine) Sales by Country
8.6.2 South America Biothrax (Anthrax Vaccine) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region
8.7.2 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BIOTHRAX (ANTHRAX VACCINE) MARKET PRODUCTION BY REGION
9.1 Global Production of Biothrax (Anthrax Vaccine) by Region(2020-2025)
9.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2020-2025)
9.3 Global Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Biothrax (Anthrax Vaccine) Production
9.4.1 North America Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.4.2 North America Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Biothrax (Anthrax Vaccine) Production
9.5.1 Europe Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.5.2 Europe Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Biothrax (Anthrax Vaccine) Production (2020-2025)
9.6.1 Japan Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.6.2 Japan Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Biothrax (Anthrax Vaccine) Production (2020-2025)
9.7.1 China Biothrax (Anthrax Vaccine) Production Growth Rate (2020-2025)
9.7.2 China Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merial
10.1.1 Merial Basic Information
10.1.2 Merial Biothrax (Anthrax Vaccine) Product Overview
10.1.3 Merial Biothrax (Anthrax Vaccine) Product Market Performance
10.1.4 Merial Business Overview
10.1.5 Merial SWOT Analysis
10.1.6 Merial Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Biothrax (Anthrax Vaccine) Product Overview
10.2.3 Merck Biothrax (Anthrax Vaccine) Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Zoetis
10.3.1 Zoetis Basic Information
10.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Overview
10.3.3 Zoetis Biothrax (Anthrax Vaccine) Product Market Performance
10.3.4 Zoetis Business Overview
10.3.5 Zoetis SWOT Analysis
10.3.6 Zoetis Recent Developments
10.4 Bayer Sanidad Animal
10.4.1 Bayer Sanidad Animal Basic Information
10.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
10.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Market Performance
10.4.4 Bayer Sanidad Animal Business Overview
10.4.5 Bayer Sanidad Animal Recent Developments
10.5 Colorado Serum
10.5.1 Colorado Serum Basic Information
10.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
10.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Product Market Performance
10.5.4 Colorado Serum Business Overview
10.5.5 Colorado Serum Recent Developments
10.6 PharmAthene
10.6.1 PharmAthene Basic Information
10.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Overview
10.6.3 PharmAthene Biothrax (Anthrax Vaccine) Product Market Performance
10.6.4 PharmAthene Business Overview
10.6.5 PharmAthene Recent Developments
10.7 Tiankang
10.7.1 Tiankang Basic Information
10.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Overview
10.7.3 Tiankang Biothrax (Anthrax Vaccine) Product Market Performance
10.7.4 Tiankang Business Overview
10.7.5 Tiankang Recent Developments
10.8 Biog?nesis-Bago
10.8.1 Biog?nesis-Bago Basic Information
10.8.2 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Overview
10.8.3 Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Market Performance
10.8.4 Biog?nesis-Bago Business Overview
10.8.5 Biog?nesis-Bago Recent Developments
10.9 CAVAC
10.9.1 CAVAC Basic Information
10.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Overview
10.9.3 CAVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.9.4 CAVAC Business Overview
10.9.5 CAVAC Recent Developments
10.10 Rosenbusch
10.10.1 Rosenbusch Basic Information
10.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
10.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Product Market Performance
10.10.4 Rosenbusch Business Overview
10.10.5 Rosenbusch Recent Developments
10.11 Agrovet
10.11.1 Agrovet Basic Information
10.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Overview
10.11.3 Agrovet Biothrax (Anthrax Vaccine) Product Market Performance
10.11.4 Agrovet Business Overview
10.11.5 Agrovet Recent Developments
10.12 Vecol
10.12.1 Vecol Basic Information
10.12.2 Vecol Biothrax (Anthrax Vaccine) Product Overview
10.12.3 Vecol Biothrax (Anthrax Vaccine) Product Market Performance
10.12.4 Vecol Business Overview
10.12.5 Vecol Recent Developments
10.13 CVCRI
10.13.1 CVCRI Basic Information
10.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Overview
10.13.3 CVCRI Biothrax (Anthrax Vaccine) Product Market Performance
10.13.4 CVCRI Business Overview
10.13.5 CVCRI Recent Developments
10.14 IVPM
10.14.1 IVPM Basic Information
10.14.2 IVPM Biothrax (Anthrax Vaccine) Product Overview
10.14.3 IVPM Biothrax (Anthrax Vaccine) Product Market Performance
10.14.4 IVPM Business Overview
10.14.5 IVPM Recent Developments
10.15 Prondil
10.15.1 Prondil Basic Information
10.15.2 Prondil Biothrax (Anthrax Vaccine) Product Overview
10.15.3 Prondil Biothrax (Anthrax Vaccine) Product Market Performance
10.15.4 Prondil Business Overview
10.15.5 Prondil Recent Developments
10.16 CDV
10.16.1 CDV Basic Information
10.16.2 CDV Biothrax (Anthrax Vaccine) Product Overview
10.16.3 CDV Biothrax (Anthrax Vaccine) Product Market Performance
10.16.4 CDV Business Overview
10.16.5 CDV Recent Developments
10.17 Indian Immunologicals
10.17.1 Indian Immunologicals Basic Information
10.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
10.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Market Performance
10.17.4 Indian Immunologicals Business Overview
10.17.5 Indian Immunologicals Recent Developments
10.18 Botswana Vaccine Institute
10.18.1 Botswana Vaccine Institute Basic Information
10.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
10.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Market Performance
10.18.4 Botswana Vaccine Institute Business Overview
10.18.5 Botswana Vaccine Institute Recent Developments
10.19 Ceva Sant? Animale
10.19.1 Ceva Sant? Animale Basic Information
10.19.2 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Overview
10.19.3 Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Market Performance
10.19.4 Ceva Sant? Animale Business Overview
10.19.5 Ceva Sant? Animale Recent Developments
10.20 Intervac
10.20.1 Intervac Basic Information
10.20.2 Intervac Biothrax (Anthrax Vaccine) Product Overview
10.20.3 Intervac Biothrax (Anthrax Vaccine) Product Market Performance
10.20.4 Intervac Business Overview
10.20.5 Intervac Recent Developments
10.21 JOVAC
10.21.1 JOVAC Basic Information
10.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Overview
10.21.3 JOVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.21.4 JOVAC Business Overview
10.21.5 JOVAC Recent Developments
11 BIOTHRAX (ANTHRAX VACCINE) MARKET FORECAST BY REGION
11.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast
11.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.3 Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region
11.2.4 South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Biothrax (Anthrax Vaccine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Biothrax (Anthrax Vaccine) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Type (2026-2035)
12.1.2 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Biothrax (Anthrax Vaccine) by Type (2026-2035)
12.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Application (2026-2035)
12.2.1 Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application
12.2.2 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Biothrax (Anthrax Vaccine) Market Size by Type (M USD)
Table 4. Global Biothrax (Anthrax Vaccine) Market Size by Application
Table 5. Biothrax (Anthrax Vaccine) Market Size Comparison by Region (M USD)
Table 6. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2025)
Table 11. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biothrax (Anthrax Vaccine) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Biothrax (Anthrax Vaccine) Sales by Type (K MT)
Table 27. Global Biothrax (Anthrax Vaccine) Market Size by Type (M USD)
Table 28. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Type (2020-2025)
Table 29. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2020-2025)
Table 30. Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Type (2020-2025)
Table 31. Global Biothrax (Anthrax Vaccine) Market Share by Type (2020-2025)
Table 32. Global Biothrax (Anthrax Vaccine) Price (USD/KG) by Type (2020-2025)
Table 33. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Application
Table 34. Global Biothrax (Anthrax Vaccine) Market Size by Application
Table 35. Global Biothrax (Anthrax Vaccine) Sales by Application (2020-2025) & (K MT)
Table 36. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2020-2025)
Table 37. Global Biothrax (Anthrax Vaccine) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Biothrax (Anthrax Vaccine) Market Share by Application (2020-2025)
Table 39. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2020-2025)
Table 40. Global Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K MT)
Table 41. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2020-2025)
Table 42. Global Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025)
Table 44. North America Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K MT)
Table 45. North America Biothrax (Anthrax Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Biothrax (Anthrax Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K MT)
Table 51. South America Biothrax (Anthrax Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Biothrax (Anthrax Vaccine) Production (K MT) by Region(2020-2025)
Table 55. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2020-2025)
Table 57. Global Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merial Basic Information
Table 63. Merial Biothrax (Anthrax Vaccine) Product Overview
Table 64. Merial Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merial Business Overview
Table 66. Merial SWOT Analysis
Table 67. Merial Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Biothrax (Anthrax Vaccine) Product Overview
Table 70. Merck Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Zoetis Basic Information
Table 75. Zoetis Biothrax (Anthrax Vaccine) Product Overview
Table 76. Zoetis Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Zoetis Business Overview
Table 78. Zoetis SWOT Analysis
Table 79. Zoetis Recent Developments
Table 80. Bayer Sanidad Animal Basic Information
Table 81. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
Table 82. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Sanidad Animal Business Overview
Table 84. Bayer Sanidad Animal Recent Developments
Table 85. Colorado Serum Basic Information
Table 86. Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
Table 87. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Colorado Serum Business Overview
Table 89. Colorado Serum Recent Developments
Table 90. PharmAthene Basic Information
Table 91. PharmAthene Biothrax (Anthrax Vaccine) Product Overview
Table 92. PharmAthene Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. PharmAthene Business Overview
Table 94. PharmAthene Recent Developments
Table 95. Tiankang Basic Information
Table 96. Tiankang Biothrax (Anthrax Vaccine) Product Overview
Table 97. Tiankang Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Tiankang Business Overview
Table 99. Tiankang Recent Developments
Table 100. Biog?nesis-Bago Basic Information
Table 101. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Overview
Table 102. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biog?nesis-Bago Business Overview
Table 104. Biog?nesis-Bago Recent Developments
Table 105. CAVAC Basic Information
Table 106. CAVAC Biothrax (Anthrax Vaccine) Product Overview
Table 107. CAVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. CAVAC Business Overview
Table 109. CAVAC Recent Developments
Table 110. Rosenbusch Basic Information
Table 111. Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
Table 112. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Rosenbusch Business Overview
Table 114. Rosenbusch Recent Developments
Table 115. Agrovet Basic Information
Table 116. Agrovet Biothrax (Anthrax Vaccine) Product Overview
Table 117. Agrovet Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Agrovet Business Overview
Table 119. Agrovet Recent Developments
Table 120. Vecol Basic Information
Table 121. Vecol Biothrax (Anthrax Vaccine) Product Overview
Table 122. Vecol Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Vecol Business Overview
Table 124. Vecol Recent Developments
Table 125. CVCRI Basic Information
Table 126. CVCRI Biothrax (Anthrax Vaccine) Product Overview
Table 127. CVCRI Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. CVCRI Business Overview
Table 129. CVCRI Recent Developments
Table 130. IVPM Basic Information
Table 131. IVPM Biothrax (Anthrax Vaccine) Product Overview
Table 132. IVPM Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. IVPM Business Overview
Table 134. IVPM Recent Developments
Table 135. Prondil Basic Information
Table 136. Prondil Biothrax (Anthrax Vaccine) Product Overview
Table 137. Prondil Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Prondil Business Overview
Table 139. Prondil Recent Developments
Table 140. CDV Basic Information
Table 141. CDV Biothrax (Anthrax Vaccine) Product Overview
Table 142. CDV Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. CDV Business Overview
Table 144. CDV Recent Developments
Table 145. Indian Immunologicals Basic Information
Table 146. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
Table 147. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Indian Immunologicals Business Overview
Table 149. Indian Immunologicals Recent Developments
Table 150. Botswana Vaccine Institute Basic Information
Table 151. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
Table 152. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Botswana Vaccine Institute Business Overview
Table 154. Botswana Vaccine Institute Recent Developments
Table 155. Ceva Sant? Animale Basic Information
Table 156. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Overview
Table 157. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Ceva Sant? Animale Business Overview
Table 159. Ceva Sant? Animale Recent Developments
Table 160. Intervac Basic Information
Table 161. Intervac Biothrax (Anthrax Vaccine) Product Overview
Table 162. Intervac Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Intervac Business Overview
Table 164. Intervac Recent Developments
Table 165. JOVAC Basic Information
Table 166. JOVAC Biothrax (Anthrax Vaccine) Product Overview
Table 167. JOVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. JOVAC Business Overview
Table 169. JOVAC Recent Developments
Table 170. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 171. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 173. North America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 175. Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Biothrax (Anthrax Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 177. Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 179. South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2026-2035) & (K MT)
Table 183. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2026-2035) & (USD/KG)
Table 185. Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application (2026-2035)
Table 186. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Biothrax (Anthrax Vaccine) Market Size by Type (M USD)
Table 4. Global Biothrax (Anthrax Vaccine) Market Size by Application
Table 5. Biothrax (Anthrax Vaccine) Market Size Comparison by Region (M USD)
Table 6. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2025)
Table 11. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biothrax (Anthrax Vaccine) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Biothrax (Anthrax Vaccine) Sales by Type (K MT)
Table 27. Global Biothrax (Anthrax Vaccine) Market Size by Type (M USD)
Table 28. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Type (2020-2025)
Table 29. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2020-2025)
Table 30. Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Type (2020-2025)
Table 31. Global Biothrax (Anthrax Vaccine) Market Share by Type (2020-2025)
Table 32. Global Biothrax (Anthrax Vaccine) Price (USD/KG) by Type (2020-2025)
Table 33. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Application
Table 34. Global Biothrax (Anthrax Vaccine) Market Size by Application
Table 35. Global Biothrax (Anthrax Vaccine) Sales by Application (2020-2025) & (K MT)
Table 36. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2020-2025)
Table 37. Global Biothrax (Anthrax Vaccine) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Biothrax (Anthrax Vaccine) Market Share by Application (2020-2025)
Table 39. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2020-2025)
Table 40. Global Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K MT)
Table 41. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2020-2025)
Table 42. Global Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025)
Table 44. North America Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K MT)
Table 45. North America Biothrax (Anthrax Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Biothrax (Anthrax Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Biothrax (Anthrax Vaccine) Sales by Country (2020-2025) & (K MT)
Table 51. South America Biothrax (Anthrax Vaccine) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Biothrax (Anthrax Vaccine) Production (K MT) by Region(2020-2025)
Table 55. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2020-2025)
Table 57. Global Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merial Basic Information
Table 63. Merial Biothrax (Anthrax Vaccine) Product Overview
Table 64. Merial Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merial Business Overview
Table 66. Merial SWOT Analysis
Table 67. Merial Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Biothrax (Anthrax Vaccine) Product Overview
Table 70. Merck Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Zoetis Basic Information
Table 75. Zoetis Biothrax (Anthrax Vaccine) Product Overview
Table 76. Zoetis Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Zoetis Business Overview
Table 78. Zoetis SWOT Analysis
Table 79. Zoetis Recent Developments
Table 80. Bayer Sanidad Animal Basic Information
Table 81. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
Table 82. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Sanidad Animal Business Overview
Table 84. Bayer Sanidad Animal Recent Developments
Table 85. Colorado Serum Basic Information
Table 86. Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
Table 87. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Colorado Serum Business Overview
Table 89. Colorado Serum Recent Developments
Table 90. PharmAthene Basic Information
Table 91. PharmAthene Biothrax (Anthrax Vaccine) Product Overview
Table 92. PharmAthene Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. PharmAthene Business Overview
Table 94. PharmAthene Recent Developments
Table 95. Tiankang Basic Information
Table 96. Tiankang Biothrax (Anthrax Vaccine) Product Overview
Table 97. Tiankang Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Tiankang Business Overview
Table 99. Tiankang Recent Developments
Table 100. Biog?nesis-Bago Basic Information
Table 101. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Product Overview
Table 102. Biog?nesis-Bago Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biog?nesis-Bago Business Overview
Table 104. Biog?nesis-Bago Recent Developments
Table 105. CAVAC Basic Information
Table 106. CAVAC Biothrax (Anthrax Vaccine) Product Overview
Table 107. CAVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. CAVAC Business Overview
Table 109. CAVAC Recent Developments
Table 110. Rosenbusch Basic Information
Table 111. Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
Table 112. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Rosenbusch Business Overview
Table 114. Rosenbusch Recent Developments
Table 115. Agrovet Basic Information
Table 116. Agrovet Biothrax (Anthrax Vaccine) Product Overview
Table 117. Agrovet Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Agrovet Business Overview
Table 119. Agrovet Recent Developments
Table 120. Vecol Basic Information
Table 121. Vecol Biothrax (Anthrax Vaccine) Product Overview
Table 122. Vecol Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Vecol Business Overview
Table 124. Vecol Recent Developments
Table 125. CVCRI Basic Information
Table 126. CVCRI Biothrax (Anthrax Vaccine) Product Overview
Table 127. CVCRI Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. CVCRI Business Overview
Table 129. CVCRI Recent Developments
Table 130. IVPM Basic Information
Table 131. IVPM Biothrax (Anthrax Vaccine) Product Overview
Table 132. IVPM Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. IVPM Business Overview
Table 134. IVPM Recent Developments
Table 135. Prondil Basic Information
Table 136. Prondil Biothrax (Anthrax Vaccine) Product Overview
Table 137. Prondil Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Prondil Business Overview
Table 139. Prondil Recent Developments
Table 140. CDV Basic Information
Table 141. CDV Biothrax (Anthrax Vaccine) Product Overview
Table 142. CDV Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. CDV Business Overview
Table 144. CDV Recent Developments
Table 145. Indian Immunologicals Basic Information
Table 146. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
Table 147. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Indian Immunologicals Business Overview
Table 149. Indian Immunologicals Recent Developments
Table 150. Botswana Vaccine Institute Basic Information
Table 151. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
Table 152. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Botswana Vaccine Institute Business Overview
Table 154. Botswana Vaccine Institute Recent Developments
Table 155. Ceva Sant? Animale Basic Information
Table 156. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Product Overview
Table 157. Ceva Sant? Animale Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Ceva Sant? Animale Business Overview
Table 159. Ceva Sant? Animale Recent Developments
Table 160. Intervac Basic Information
Table 161. Intervac Biothrax (Anthrax Vaccine) Product Overview
Table 162. Intervac Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Intervac Business Overview
Table 164. Intervac Recent Developments
Table 165. JOVAC Basic Information
Table 166. JOVAC Biothrax (Anthrax Vaccine) Product Overview
Table 167. JOVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. JOVAC Business Overview
Table 169. JOVAC Recent Developments
Table 170. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 171. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 173. North America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 175. Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Biothrax (Anthrax Vaccine) Sales Forecast by Region (2026-2035) & (K MT)
Table 177. Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (K MT)
Table 179. South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2026-2035) & (K MT)
Table 183. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2026-2035) & (USD/KG)
Table 185. Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application (2026-2035)
Table 186. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biothrax (Anthrax Vaccine) Market Size (M USD), 2025-2035
Figure 5. Global Biothrax (Anthrax Vaccine) Market Size (M USD) (2020-2035)
Figure 6. Global Biothrax (Anthrax Vaccine) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biothrax (Anthrax Vaccine) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biothrax (Anthrax Vaccine) Product Life Cycle
Figure 13. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2025
Figure 14. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2025
Figure 15. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biothrax (Anthrax Vaccine) Revenue in 2025
Figure 18. Industry Chain Map of Biothrax (Anthrax Vaccine)
Figure 19. Global Biothrax (Anthrax Vaccine) Market PEST Analysis
Figure 20. Global Biothrax (Anthrax Vaccine) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biothrax (Anthrax Vaccine) Market Share by Type
Figure 27. Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2020-2025)
Figure 28. Sales Market Share of Biothrax (Anthrax Vaccine) by Type in 2025
Figure 29. Market Share of Biothrax (Anthrax Vaccine) by Type (2020-2025)
Figure 30. Market Share of Biothrax (Anthrax Vaccine) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biothrax (Anthrax Vaccine) Market Share by Application
Figure 33. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2020-2025)
Figure 34. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application in 2025
Figure 35. Global Biothrax (Anthrax Vaccine) Market Share by Application (2020-2025)
Figure 36. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2025
Figure 37. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2020-2025)
Figure 39. Global Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025)
Figure 40. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2024
Figure 43. North America Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biothrax (Anthrax Vaccine) Market Size by Country in 2024
Figure 45. U.S. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biothrax (Anthrax Vaccine) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biothrax (Anthrax Vaccine) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biothrax (Anthrax Vaccine) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biothrax (Anthrax Vaccine) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2024
Figure 53. Europe Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biothrax (Anthrax Vaccine) Market Size by Country in 2024
Figure 55. Germany Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region in 2024
Figure 68. China Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 79. South America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2024
Figure 80. South America Biothrax (Anthrax Vaccine) Market Size and Growth Rate (M USD)
Figure 81. South America Biothrax (Anthrax Vaccine) Market Size by Country in 2024
Figure 82. Brazil Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Region in 2024
Figure 92. Saudi Arabia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biothrax (Anthrax Vaccine) Production Market Share by Region (2020-2025)
Figure 103. North America Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biothrax (Anthrax Vaccine) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Type (2026-2035)
Figure 111. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2026-2035)
Figure 112. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biothrax (Anthrax Vaccine) Market Size (M USD), 2025-2035
Figure 5. Global Biothrax (Anthrax Vaccine) Market Size (M USD) (2020-2035)
Figure 6. Global Biothrax (Anthrax Vaccine) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biothrax (Anthrax Vaccine) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Biothrax (Anthrax Vaccine) Product Life Cycle
Figure 13. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2025
Figure 14. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2025
Figure 15. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Biothrax (Anthrax Vaccine) Revenue in 2025
Figure 18. Industry Chain Map of Biothrax (Anthrax Vaccine)
Figure 19. Global Biothrax (Anthrax Vaccine) Market PEST Analysis
Figure 20. Global Biothrax (Anthrax Vaccine) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Biothrax (Anthrax Vaccine) Market Share by Type
Figure 27. Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2020-2025)
Figure 28. Sales Market Share of Biothrax (Anthrax Vaccine) by Type in 2025
Figure 29. Market Share of Biothrax (Anthrax Vaccine) by Type (2020-2025)
Figure 30. Market Share of Biothrax (Anthrax Vaccine) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Biothrax (Anthrax Vaccine) Market Share by Application
Figure 33. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2020-2025)
Figure 34. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application in 2025
Figure 35. Global Biothrax (Anthrax Vaccine) Market Share by Application (2020-2025)
Figure 36. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2025
Figure 37. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2020-2025)
Figure 39. Global Biothrax (Anthrax Vaccine) Market Size by Region (2020-2025)
Figure 40. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2024
Figure 43. North America Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Biothrax (Anthrax Vaccine) Market Size by Country in 2024
Figure 45. U.S. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Biothrax (Anthrax Vaccine) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Biothrax (Anthrax Vaccine) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Biothrax (Anthrax Vaccine) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Biothrax (Anthrax Vaccine) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2024
Figure 53. Europe Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Biothrax (Anthrax Vaccine) Market Size by Country in 2024
Figure 55. Germany Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Region in 2024
Figure 68. China Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 79. South America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2024
Figure 80. South America Biothrax (Anthrax Vaccine) Market Size and Growth Rate (M USD)
Figure 81. South America Biothrax (Anthrax Vaccine) Market Size by Country in 2024
Figure 82. Brazil Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Region in 2024
Figure 92. Saudi Arabia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Biothrax (Anthrax Vaccine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Biothrax (Anthrax Vaccine) Production Market Share by Region (2020-2025)
Figure 103. North America Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Biothrax (Anthrax Vaccine) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Type (2026-2035)
Figure 111. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2026-2035)
Figure 112. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Application (2026-2035)
